<DOC>
	<DOCNO>NCT01809236</DOCNO>
	<brief_summary>This Phase II , single arm , open label clinical trial . 60 RVO patient ( include 30 BRVO 30 CRVO , respectively ) enrol study . The study include fixed treatment period ( 3 month ) PRN period ( 6 month ) . In fixed treatment period patient receive 3 consecutive monthly intravitreal 0.5 mg Conbercept . In PRN period , patient monthly visit retreatment need accord retreatment criterion pre-specified .</brief_summary>
	<brief_title>Efficacy Safety Conbercept Macular Edema Secondary Retinal Vein Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<criteria>1 . Ability willingness provide sign Informed Consent Form . 2 . Age ≥ 18 , male female。 3 . Ocular Inclusion Criterion ( Study Eye ) : Diagnosis Foveal centerinvolved macular edema due RVO ( CRVO BRVO ) within 6 month . Best correct visual acuity ( BCVA ) letter score study eye ≤ 73（Snellen equivalent 20/40） . Central retinal thickness OCT study eye ≥ 320 μm . 1 . Brisk afferent pupillary defect . 2 . History antiVEGF treatment study and/or system within 6 month enrollment , and/or fellow eye within 3 month . 3 . History intraocular and/or periocular corticosteroid use study eye within 3 month , and/or history use steroid systemic ( p.o. , i.m. , i.v . ) within 1 month . 4 . Any active infection involve ocular include blepharitis , infectious conjunctivitis , keratitis , scleritis , endophthalmitis either eye . 5 . Any inflammatory cell detect anterior chamber and/or vitreous study eye . 6 . Presence nonRVO disease , opinion investigator , might cause macular edema , AMD ( wet dry ) , diabetes retinopathy , uveitis etc . 7 . Neovascular change study eye and/or neovascularization iris neovascular glaucoma study eye baseline . 8 . Patients substantial cataract , opinion investigator , likely decrease visual acuity equal 3 line medicine surgery treatment need study eye within 4 month . 9 . Patients diagnose systemic immune disease uncontrolled clinical disease . 10 . Pregnant nursing woman . 11 . Patients need exclude opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>